期刊文献+

肾脏有机阳离子转运体2在急性肾损伤中病理生理调控的研究进展 被引量:7

Pathophysiological regulation of renal organic cation transporter 2(OCT2) in acute kidney injury: a review
原文传递
导出
摘要 有机阳离子转运体2(organic cation transporter 2,OCT2)是溶质转运体(solute carriers,SLC)超家族中SLC22A家族的重要成员之一。肾小管上皮细胞基底膜侧表达的OCT2在维持机体内环境平衡方面起着重要作用,是肾脏主动分泌众多内、外源性有机阳离子型化合物(包括环境毒素、药物以及内源性代谢产物等)的主要转运体。在急性肾损伤(acute kidney injury,AKI)期间,OCT2功能与表达的改变对其底物的清除具有巨大的影响,可导致药物的药代动力学过程发生改变,从而影响药物的安全性和有效性。现就OCT2的结构与分布、生理作用与调控机制以及在各种因素诱导的AKI中的功能与表达变化和病理生理调控等方面进行综述,旨在为临床合理用药提供参考。 Orangic cation transporter 2(OCT2) is an important member of superfamily of solute carriers 22 A(SLC22 A). As a major transporter involved in both endogenous and exogenous active secretion in the basolateral of renal tubular epithelial, OCT2 can transport drugs, toxins and endogenous by-products in kidney, and therefore, plays an important role in maintaining the homeostasis of internal environment. Under the circumstance of acute kidney injury(AKI), the functional and expressional variations of renal OCT2 have a huge impact on systemic clearance of substrate drugs, thereby affecting the safety and efficacy of the drug. This review highlights the structure and distribution of OCT2, its physiological effects and regulation mechanism, as well as its function and expression changes and pathophysiological regulation in a variety of factors inducing AKI, aiming to provide theoretical basis for the rational use of drugs.
作者 戴永国 陈李杰 王崴 杨世磊 DAI Yong-Guo;CHEN Li-Jie;WANG Wei;YANG Shi-Lei(Department of Pharmacy,The First Affiliated Hospital of Dalian Medical University,Dalian 116011,China;College of Pharmacy,Dalian Medical University,Dalian 116044,China)
出处 《生命科学》 CSCD 北大核心 2018年第7期790-797,共8页 Chinese Bulletin of Life Sciences
基金 国家自然科学基金项目(81603186)
关键词 有机阳离子转运体2 急性肾损伤 调控 organic cation transporter 2 acute kidney injury regulation
  • 相关文献

参考文献4

二级参考文献44

  • 1李毅,彭鹏.血液净化技术在急性中毒救治中的临床应用[J].中国全科医学,2009,12(8):666-668. 被引量:14
  • 2李保春,翟振燕.上海市血液净化中心透析用水及透析液细菌污染情况调查[J].中国血液净化,2005,4(1):52-54. 被引量:23
  • 3刘冬妍,李航,李学旺.血浆置换在危重症疾病治疗中的应用进展[J].国际移植与血液净化杂志,2006,4(1):1-4. 被引量:13
  • 4谷红霞,刘子栋,高鑫,张明.高通量血液透析与常规血液透析、血液透析滤过的透析效果比较[J].临床军医杂志,2006,34(5):535-538. 被引量:19
  • 5Bodo A, Bakos E, Szeri F, et al. The role of multidrug transporters in drug availability, metabolism and toxicity [ J ]. Toxicol Lett, 2003, 140-141:133-143.
  • 6Urakami Y, Akazawa M, Saito H, et al. eDNA cloning, functional characterization,and tissue distribution of an alternatively spliced variant of organic cation transporter hOCT2 predominantly expressed in the human kidney [J]. J Am Soc Nephrol, 2002, 13 (7) :1703-1710.
  • 7Motohashi H, Sakurai Y, Saito H, et al. Gene expression levels and immunolocalization of organic ion transporters in the human kidney [ J ]. J Am Soc Nephro ,2002,13 (4) :866-874.
  • 8Sweet DH, Miller DS, Pritchard JB: Basolateral localization of organic cation transporter 2 in intact renal proximal tubules [ J ]. Am J Physiol Renal Physiol,2000,279 (5) : F826-F834.
  • 9Barendt WM, Wright SH. The human organic cation transporter (hOCT2) recognizes the degree of substrate ionization [ J ]. J Biol Chem ,2002,277 ( 25 ) :22491-22496.
  • 10Urakami Y, Okuda M, Saito H ,et al. Hormonal regulation of organic cation transporter OCT2 expression in rat kidney [ J ]. FEBS Lett ,2000,473 (2) : 173-176.

共引文献65

同被引文献70

引证文献7

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部